Patent details
EP2934591 Title: SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE
Basic Information
- Publication number:
- EP2934591
- PCT Application Number:
- EP2013077300
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP138190210
- PCT Publication Number:
- WO2014096139
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE
- French Title of Invention:
- FORME PHARMACEUTIQUE ORALE SOLIDE DE DÉRIVÉ DE TESTOSTÉRONE
- German Title of Invention:
- FESTE ORALE DARREICHUNGSFORM EINES TESTOSTERONDERIVATS
- SPC Number:
Dates
- Filing date:
- 19/12/2013
- Grant date:
- 09/08/2017
- EP Publication Date:
- 28/10/2015
- PCT Publication Date:
- 26/06/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/08/2017
- EP B1 Publication Date:
- 09/08/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/12/2017
- Expiration date:
- 19/12/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/08/2017
- Name:
- Solural Pharma Aps
- Address:
- Energivej 42, 2750 Ballerup, Denmark (DK)
Inventor
- Name:
- HØJGAARD, Bent
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 12198529
- Priority Date:
- 20/12/2012
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/107; A61K 9/20; A61K 9/66; A61K 31/569; A61K 47/14; A61K 47/44;
Publication
European Patent Bulletin
- Issue number:
- 201732
- Publication date:
- 09/08/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/04/2018 | Outgoing Correspondence | 1 |